Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common variations have confounded doctors and left anxious patients without guidance ...

Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases. Mercy Medical Center Dr ...

Recent studies have identified risks in BRCA2 gene mutations, leading to better cancer risk assessment and treatment. Other ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results ...

Scientists at Children’s Medical Research Institute (CMRI) have solved a remarkable puzzle in cancer research: why cells die ...